2-61824906-C-A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_001201543.2(FAM161A):​c.*1549G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00417 in 450,042 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0098 ( 24 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 13 hom. )

Consequence

FAM161A
NM_001201543.2 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.880

Publications

0 publications found
Variant links:
Genes affected
FAM161A (HGNC:25808): (FAM161 centrosomal protein A) This gene belongs to the FAM161 family. It is expressed mainly in the retina. Mouse studies suggested that this gene is involved in development of retinal progenitors during embryogenesis, and that its activity is restricted to mature photoreceptors after birth. Mutations in this gene cause autosomal recessive retinitis pigmentosa-28. Alternatively spliced transcript variants have been identified.[provided by RefSeq, Jan 2011]
FAM161A Gene-Disease associations (from GenCC):
  • retinitis pigmentosa 28
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00981 (1493/152188) while in subpopulation AFR AF = 0.0346 (1438/41518). AF 95% confidence interval is 0.0331. There are 24 homozygotes in GnomAd4. There are 694 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 24 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAM161ANM_001201543.2 linkc.*1549G>T 3_prime_UTR_variant Exon 7 of 7 ENST00000404929.6 NP_001188472.1 Q3B820-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAM161AENST00000404929.6 linkc.*1549G>T 3_prime_UTR_variant Exon 7 of 7 1 NM_001201543.2 ENSP00000385158.1 Q3B820-3

Frequencies

GnomAD3 genomes
AF:
0.00979
AC:
1489
AN:
152070
Hom.:
24
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0346
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00256
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00224
AC:
280
AN:
124740
AF XY:
0.00186
show subpopulations
Gnomad AFR exome
AF:
0.0379
Gnomad AMR exome
AF:
0.00170
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000646
Gnomad OTH exome
AF:
0.000776
GnomAD4 exome
AF:
0.00129
AC:
383
AN:
297854
Hom.:
13
Cov.:
0
AF XY:
0.00102
AC XY:
173
AN XY:
169874
show subpopulations
African (AFR)
AF:
0.0371
AC:
305
AN:
8214
American (AMR)
AF:
0.00178
AC:
47
AN:
26408
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
10580
East Asian (EAS)
AF:
0.00
AC:
0
AN:
9334
South Asian (SAS)
AF:
0.000154
AC:
9
AN:
58300
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
12248
Middle Eastern (MID)
AF:
0.000896
AC:
1
AN:
1116
European-Non Finnish (NFE)
AF:
0.0000570
AC:
9
AN:
157816
Other (OTH)
AF:
0.000867
AC:
12
AN:
13838
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
17
33
50
66
83
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00981
AC:
1493
AN:
152188
Hom.:
24
Cov.:
32
AF XY:
0.00933
AC XY:
694
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.0346
AC:
1438
AN:
41518
American (AMR)
AF:
0.00255
AC:
39
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10594
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68010
Other (OTH)
AF:
0.00379
AC:
8
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
74
148
222
296
370
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00498
Hom.:
4
Bravo
AF:
0.0113
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Retinitis pigmentosa Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
0.36
DANN
Benign
0.73
PhyloP100
-0.88
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7563900; hg19: chr2-62052041; API